A detailed history of Trinity Point Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Trinity Point Wealth, LLC holds 8,369 shares of AMGN stock, worth $2.19 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
8,369
Previous 8,306 0.76%
Holding current value
$2.19 Million
Previous $2.6 Million 3.89%
% of portfolio
0.4%
Previous 0.41%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$309.38 - $337.38 $19,490 - $21,254
63 Added 0.76%
8,369 $2.7 Million
Q2 2024

Jul 30, 2024

BUY
$262.75 - $319.31 $78,299 - $95,154
298 Added 3.72%
8,306 $2.6 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $51,354 - $61,990
191 Added 2.44%
8,008 $2.28 Million
Q4 2023

Feb 08, 2024

SELL
$255.7 - $288.46 $22,245 - $25,096
-87 Reduced 1.1%
7,817 $2.25 Million
Q3 2023

Nov 08, 2023

BUY
$218.65 - $271.46 $41,980 - $52,120
192 Added 2.49%
7,904 $2.12 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $90,850 - $107,428
424 Added 5.82%
7,712 $1.71 Million
Q1 2023

May 04, 2023

BUY
$225.79 - $275.2 $53,963 - $65,772
239 Added 3.39%
7,288 $1.76 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $10,535 - $13,386
46 Added 0.66%
7,049 $1.85 Million
Q3 2022

Nov 09, 2022

BUY
$224.46 - $253.15 $84,172 - $94,931
375 Added 5.66%
7,003 $1.58 Million
Q2 2022

Aug 05, 2022

BUY
$230.71 - $256.74 $132,427 - $147,368
574 Added 9.48%
6,628 $1.61 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $46,265 - $51,182
211 Added 3.61%
6,054 $1.46 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $85,120 - $97,412
-428 Reduced 6.83%
5,843 $1.31 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $122,479 - $143,499
577 Added 10.13%
6,271 $1.33 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $15,883 - $17,621
68 Added 1.21%
5,694 $1.39 Million
Q1 2021

May 11, 2021

BUY
$221.91 - $258.6 $20,193 - $23,532
91 Added 1.64%
5,626 $1.4 Million
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $55,176 - $65,705
255 Added 4.83%
5,535 $1.43 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $25,576 - $28,443
-109 Reduced 2.02%
5,280 $1.34 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $62,112 - $76,220
-314 Reduced 5.51%
5,389 $1.27 Million
Q1 2020

May 05, 2020

BUY
$182.24 - $241.7 $72,896 - $96,680
400 Added 7.54%
5,703 $1.16 Million
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $114,850 - $147,622
-607 Reduced 10.27%
5,303 $1.28 Million
Q3 2019

Nov 07, 2019

BUY
$174.11 - $208.62 $1.03 Million - $1.23 Million
5,910 New
5,910 $1.27 Million
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $183,703 - $215,341
-1,102 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$180.87 - $203.88 $5,968 - $6,728
33 Added 3.09%
1,102 $209,000
Q4 2018

Feb 11, 2019

BUY
$178.4 - $208.25 $190,709 - $222,619
1,069 New
1,069 $208,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Trinity Point Wealth, LLC Portfolio

Follow Trinity Point Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trinity Point Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trinity Point Wealth, LLC with notifications on news.